Remove 2022 Remove Safety Remove Treatment
article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

times more likely to achieve their treatment goals with medical cannabis. A 2023 study in Cannabis and Cannabinoid Research validated this approach, showing that patients following slower titration schedules had 84% treatment satisfaction compared to 61% with faster increases. ” Absolutely. “What About Tolerance?

article thumbnail

Jared Shaw Could Face the Death Penalty for Edibles in Indonesia

Veriheal

In 2022, Shaw moved to Indonesia, playing for several teams in the Indonesian Basketball League. While yes, we agree that there should be age restrictions and other safety laws governing the sale and use of cannabis, current legislations do more harm to our communities than good. Not only are Black people, like Shaw, 3.73

Edibles 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Scott of Pot At It Again. Cann Group aiming for over-the-counter CBD approval in late 2022

Cannabis Law Report

Phase I clinical trial of the Satipharm CBD capsules in which results demonstrated the safety and high performance of the oral capsule technology, including the superior delivery profile of cannabidiol (CBD) compound to trial subjects. The treatment was generally well tolerated and the median reduction in seizures was 81.9%

article thumbnail

Michigan Cannabis Industry Must Be Prepared for Environmental, Health, and Safety Compliance Inspections from EGLE and MIOSHA

Dykema (Cannabis Law Blog)

As the Michigan cannabis industry continues to grow and mature, medical and adult-use licensees would be well served to take proactive steps to ensure compliance with Environmental, Health and Safety (EHS) regulations. Indeed, in November 2021, the MRA sent a voluntary survey to licensed processors across the State of Michigan.

article thumbnail

CBD Market Report

Project CBD

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: [link] Accessed October 17, 2022. February 2, 2022.

CBD 143
article thumbnail

Progress for Patients in Washington, D.C.: Residents Ages 21+ Can Temporarily Self-Certify

Veriheal

On July 6, 2022, Washington, D.C. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C. law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. implemented a revolutionary emergency amendment to its medical cannabis program.

article thumbnail

District of Columbia Provides Employment Protections to Cannabis Users

The Blunt Truth

Last month, on July 13, 2022, Washington, D.C. Mayor Muriel Bowser signed the “ Cannabis Employment Protections Amendment Act of 2022 ” (D.C. The District of Columbia legalized cannabis for medicinal purposes in 2010 and began to permit individuals to use the drug recreationally in 2015.

Safety 111